#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14392	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	665.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	898	C	832	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25934	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3787	683.4	0	.	n	.	0	T695C	SNP	695	695	T	1092	1092	C	816	C	758	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25934	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3787	683.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1734	1734	A	855	A,G	783,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25934	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3787	683.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2368	2368	C	785	C	734	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25934	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3787	683.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2994	2994	T	782	T,C	732,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25934	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3787	683.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2442	2442	A	818	A	767	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	V36A	NONSYN	106	108	GTG	468	470	GCG	186;188;185	G;C;G	173;174;172	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	510	512	CGG	177;180;183	C;G;G	166;169;170	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	S68L	NONSYN	202	204	TCG	564	566	TTG	167;164;161	T;T,C;G	152;151,1;148	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	A90V	NONSYN	268	270	GCG	630	632	GTT	176;174;172	G;T;T	167;160;162	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	I105V	NONSYN	313	315	ATT	675	677	GTT	166;168;168	G;T;T	157;155;159	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	N125T	NONSYN	373	375	AAT	735	737	ACC	186;187;188	A;C;C	174;177;176	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	R135C	NONSYN	403	405	CGT	765	767	TGT	187;187;185	T;G;T	166;170;163	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	K151E	NONSYN	451	453	AAA	813	815	GAA	145;145;145	G;A;A	143;141;141	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	T152N	NONSYN	454	456	ACC	816	818	AAC	146;148;148	A;A;C	142;144;144	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	A172T	NONSYN	514	516	GCG	876	878	ACA	131;132;132	A;C;A	121;122;121	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	A175E	NONSYN	523	525	GCG	885	887	GAA	133;136;138	G;A;A	124;126;128	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	E176T	NONSYN	526	528	GAA	888	890	ACC	138;143;144	A;C;C	126;131;133	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	I178V	NONSYN	532	534	ATC	894	896	GTC	145;143;141	G;T;C	133;131;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	I188T	NONSYN	562	564	ATA	924	926	ACG	151;153;152	A;C;G	140;143;142	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	P200N	NONSYN	598	600	CCC	960	962	AAC	140;140;142	A;A;C	131;129;132	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1020	1022	TTG	153;153;154	T;T;G,A	142;141;144,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1077	1079	ACC	142;141;141	A;C;C,A	127;128;128,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1080	1082	GAC	144;144;147	G;A;C	131;131;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1089	1091	GCG	159;158;157	G;C;G,A	142;118;139,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1125	1127	GCT	153;155;155	G;C;T,G	138;140;141,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1652	folP	858	858	91.61	folP.l15.c17.ctg.1	1642	100.1	1	SNP	p	R230S	1	.	.	688	690	AGC	1050	1052	AGC	169;169;170	A;G;C	157;159;161	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5388	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3618	148.5	1	SNP	p	S91F	0	.	.	271	273	TCC	692	694	TCC	196;197;199	T;C;C	187;188;191	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5388	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3618	148.5	1	SNP	p	D95G	0	.	.	283	285	GAC	704	706	GAC	200;200;200	G;A;C	184;185;185	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5388	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3618	148.5	1	SNP	p	D95N	0	.	.	283	285	GAC	704	706	GAC	200;200;200	G;A;C	184;185;185	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1690	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1320	127.6	1	SNP	p	G45D	1	.	.	133	135	GAC	442	444	GAC	201;200;199	G;A;C	192;190;190	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	850	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1033	81.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5294	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2951	178.6	1	SNP	p	D86N	0	.	.	256	258	GAC	622	624	GAC	239;239;240	G;A;C	218;213;218	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5294	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2951	178.6	1	SNP	p	S87I	0	.	.	259	261	AGT	625	627	AGT	243;241;245	A,G;G;T	218,1;219;216	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5294	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2951	178.6	1	SNP	p	S87W	0	.	.	259	261	AGT	625	627	AGT	243;241;245	A,G;G;T	218,1;219;216	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5294	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2951	178.6	1	SNP	p	S87R	0	.	.	259	261	AGT	625	627	AGT	243;241;245	A,G;G;T	218,1;219;216	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5294	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2951	178.6	1	SNP	p	S88P	0	.	.	262	264	TCC	628	630	TCC	243;244;246	T;C;C,A	218;218;217,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4266	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2592	163.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1519	1521	GGC	194;191;192	G;G;C	186;183;182	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1204	1206	GCA	210;211;211	G;C,A;A	191;192,1;196	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1207	1209	ATC	211;211;215	A;T;CAAA,CAA	197;195;200,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1219	1221	GTG	223;224;221	G;T;G	208;208;203	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1219	1221	GTG	223;224;221	G;T;G	208;208;203	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1723	1725	ACC	199;200;202	A;C;C	183;186;189	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1777	1779	GCG	189;186;184	G;C;G	165;147;154	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1777	1779	GCG	189;186;184	G;C;G	165;147;154	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1900	1902	GGC	177;175;175	G;G;C	159;155;155	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1909	1911	GGC	169;167;165	G;G;C,T	153;149;149,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3842	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2325	164.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1927	1929	CCG	148;152;148	C,G;C;G	116,4;119;115	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5458	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3159	172.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2222	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1667	132.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	509	509	C	149	C,T	136,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	G38E	NONSYN	112	114	GGA	447	449	GAA	257;259;257	G;A;A	227;233;231	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	S46G	NONSYN	136	138	AGC	471	473	GGC	252;254;255	G;G;C	230;233;234	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	477	479	GGA	255;256;257	G;G,A;A	231;230,1;232	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	T87A	NONSYN	259	261	ACT	594	596	GCT	193;195;199	G;C;T	182;184;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	600	602	AGC	203;202;197	A;G;C	187;187;182	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	692	693	CG	208;207	C;G	199;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	695	697	CAG	208;207;206	C,A;A;G	197,1;196;196	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	699	701	AAA	209;206;205	A;A;A	200;198;195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	762	764	GAA	231;232;232	G;A;A	214;213;213	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	786	788	GCA	231;231;235	G;C;A	213;214;213	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	A215T	NONSYN	643	645	GCT	978	980	ACT	219;219;215	A;C;T	203;207;203	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	I218M	NONSYN	652	654	ATA	987	989	ATG	214;211;209	A;T;G	204;201;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1101	1103	GCA	190;191;188	G;C;A	181;181;176	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1104	1106	ACG	189;188;189	A;C,T;G	179;179,1;181	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1107	1109	GGG	193;195;195	G,A;G;G,C	182,1;184;183,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1110	1112	GTT	191;190;190	G;T,G;T	180;176,1;179	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1170	1172	GTA	224;225;221	G;TAA,TA;A	203;210,1;201	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1209	1211	ACT	222;222;224	A;C,T;T	202;206,1;209	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1215	1217	GAT	219;219;219	G;A;T	203;201;203	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1227	1229	CAC	214;217;212	C;A;C	197;200;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	1	SNP	p	G120K	1	.	.	358	360	AAG	692	694	CGG	208;207;206	C;G;G	199;197;195	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	1	SNP	p	D121N	0	.	.	361	363	GAC	695	698	CGC	208;206;208	C,A;G;C	197,1;196;198	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2640	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1518	173.0	1	SNP	p	A121D	1	.	.	361	363	GAC	695	698	CGC	208;206;208	C,A;G;C	197,1;196;198	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9810	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4981	196.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2138	2140	CAT	200;202;202	C,A;A;T	187,1;190;188	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	998	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1068	93.1	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	188;190;193	A;T;G	171;175;177	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
